novo nordisk - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Novo Nordisk split puts Hims & Hers future in question

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to partner with other Big Pharma names?

CBS News on MSN · 2d

Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing"

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

The Wall Street Journal on MSN · 1d

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims’ compounding and deceptive marketing practices.

22h

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

1hon MSN

Novo Nordisk A/S (NVO): “How Could They Be So Far Behind?,” Wonders Jim Cramer

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm’s ...

Fierce Pharma3h

Novo Nordisk questioned over controversial Spanish obesity awareness campaign

Novo Nordisk is under fire over a Spanish obesity awareness campaign. | Novo Nordisk is under fire over a Spanish obesity ...

1don MSN

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...

9hon MSN

Novo Nordisk Fast-Tracks Amycretin to Phase 3 for Obesity Treatment

Novo Nordisk (NYSE: NVO) is one of the most active stocks to buy according to analysts. On June 20, Novo Nordisk announced ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results